This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
47,18 €
Share price
0.00%
Change (1 day)
31.62%
Change (1 year)
Categories
Earnings for ChemoCentryx (CCXI)
Earnings in 2022 (TTM): -€0.12 Billion
According to ChemoCentryx's latest financial reports the company's current earnings are €37.2 Million. In 2021 the company made an earning of -€0.12 Billion a decrease over its 2020 earnings that were of -€47.84 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for ChemoCentryx from 2011 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | -€0.12 Billion | 0.47% |
| 2021 | -€0.12 Billion | 144.84% |
| 2020 | -€47.84 Million | -1.18% |
| 2019 | -€48.41 Million | 45.17% |
| 2018 | -€33.34 Million | -305.69% |
| 2017 | €16.2 M | -144.7% |
| 2016 | -€36.27 Million | -15.52% |
| 2015 | -€42.93 Million | 0.85% |
| 2014 | -€42.57 Million | 21.47% |
| 2013 | -€35.04 Million | -1.24% |
| 2012 | -€35.48 Million | 906.88% |
| 2011 | -€3.53 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | €1.72 B | -1,559.42% | 🇺🇸 USA |
 | €3.37 B | -2,945.33% | 🇺🇸 USA |
 | €3.98 B | -3,464.89% | 🇬🇧 UK |
 | -€7.61 Billion | 6,315.77% | 🇺🇸 USA |
 | €15.82 B | -13,455.28% | 🇺🇸 USA |
 | €4.18 B | -3,629.10% | 🇺🇸 USA |
 | €10.08 B | -8,609.19% | 🇺🇸 USA |
 | -€0.26 Billion | 115.93% | 🇮🇱 Israel |
 | €19.24 B | -16,338.13% | 🇺🇸 USA |